Department of Surgery, Atakent Hospital, Acibadem University, Halkali, 34678 Istanbul, Turkey.
Department of Pathology, Baskent University Istanbul Hospital, Altunizade, 34567 Istanbul, Turkey.
Gastroenterol Res Pract. 2014;2014:564949. doi: 10.1155/2014/564949. Epub 2014 Nov 9.
Introduction. The role of chronic cholestasis (CC) in liver injury and fibrosis remains unclear. The aims of this study were to define the role of endothelial nitric oxide synthase (e-NOS) in CC and the protective effect of N-acetyl-L-cysteine (NAC) in liver and kidney injury. Materials and Methods. Group A (sham group); Group B (CBDL); and Group C (CBDL + NAC). Group C received daily dosage of NAC (100 mg/kg) intraperitoneally for up to 4 weeks. Results. The rate of bridging fibrosis was higher (100% versus 20%, P = .025), but the intensity of e-NOS in liver was lower in rats that received NAC (1.3 versus 2.7, P = .046). The necrotic area in the kidneys among rats that received NAC was lower at week 4 (48% versus 57%; P < .001). The numbers of e-NOS stained cells in kidney were similar in sham group and the two groups with CBDL. Discussion. NAC reduced the stimulus for liver fibrosis in this rat model of CC and attenuated liver and kidney injury. Our study showed that e-NOS expression increased in liver tissue of rats with CC and that this was reversed by NAC. Treatment with NAC might restore e-NOS protein expression and prevent liver injury in CC.
介绍。慢性胆汁淤积(CC)在肝损伤和纤维化中的作用仍不清楚。本研究的目的是定义内皮型一氧化氮合酶(e-NOS)在 CC 中的作用,以及 N-乙酰-L-半胱氨酸(NAC)在肝和肾损伤中的保护作用。
材料和方法。A 组(假手术组);B 组(CBDL 组);C 组(CBDL+NAC 组)。C 组每天腹腔内给予 NAC(100mg/kg),持续 4 周。
结果。桥接纤维化的发生率更高(100%对 20%,P =.025),但接受 NAC 的大鼠肝组织中 e-NOS 的强度较低(1.3 对 2.7,P =.046)。第 4 周时,接受 NAC 的大鼠肾脏的坏死面积较低(48%对 57%;P <.001)。在假手术组和 CBDL 的两组大鼠中,肾脏中染色的 e-NOS 细胞数量相似。
讨论。NAC 减少了这种 CC 大鼠模型中的肝纤维化刺激,并减轻了肝和肾损伤。我们的研究表明,CC 大鼠肝组织中 e-NOS 的表达增加,而 NAC 可逆转这种情况。NAC 的治疗可能恢复 e-NOS 蛋白表达,预防 CC 中的肝损伤。